AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglip M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaglip M 50mg/500mg Tablet

Metformin/Sitagliptin 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. This medication may be used alone or in conjunction with other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Continued commitment to the prescribed diet and exercise regimen is crucial. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication is not universally suitable. Individuals with pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption should inform their physician before starting treatment. Pregnant or lactating women should consult their doctor. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout treatment.

Uses of Sitaglip M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaglip M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the 50mg/500mg Sitaglip M tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitaglip M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglip M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/500mg Sitaglip M tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Sitaglip M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitaglip M 50mg/500mg tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and heightens insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglip M 50mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaglip M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitaglip M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglip M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The medication is contraindicated in patients exhibiting severe kidney disease. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Sitaglip M 50mg/500mg tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Sitaglip M 50mg/500mg Tablet :

Should you forget a Sitaglip M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sitaglip M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitaglip M 50mg/500mg Tablet

Sitaglip M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release from the pancreas by inhibiting DPP-4. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitaglip M 50mg/500mg tablets can lead to Vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia and neurological complications such as paresthesia in the extremities, general weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake is recommended annually by some researchers.
Sitaglip M 50mg/500mg tablets may cause common side effects such as low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglip M 50mg/500mg Tablet ingredient or excipient should not take this medication. This medicine is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglip M 50mg/500mg Tablet and alcohol is unsafe due to the heightened risk of lactic acidosis.
Maintain this medication within its original, tightly sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Sitagliptin/Metformin and prompt medical attention.
Sitaglip M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise program. Metformin reduces glucose production by the liver and enhances insulin responsiveness. Sitagliptin blocks DPP4, boosting insulin secretion from the pancreas. This combination therapy is unsuitable for individuals under 18 years old.
Sitaglip M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglip M 50mg/500mg Tablet constituents or inactive ingredients should not take this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglip M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms might include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglip M 50mg/500mg tablets can lead to Vitamin B12 deficiency due to impaired absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures suggested by some studies include supplemental Vitamin B12 at least annually.
Retain this medication in its original, tightly sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitaglip M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This formulation is unsuitable for individuals under 18.
Sitaglip M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglip M 50mg/500mg Tablet ingredient or inactive component should not take this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglip M 50mg/500mg Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. If these symptoms appear, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglip M 50mg/500mg tablets can lead to vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include annual supplemental vitamin B12 intake.
Maintain this medication within its original, tightly sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitaglip M 50mg/500mg Tab...
116
MRP 135
14% off